systemic thromboembolic events
Showing 1 - 25 of >10,000
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial
Withdrawn
- Cerebral Stroke
- +2 more
- (no location specified)
Nov 14, 2021
Solid Carcinoma Trial (thrombogram)
Not yet recruiting
- Solid Carcinoma
- thrombogram
- (no location specified)
Sep 20, 2023
Identify and Describe Predictive Factors for Thromboembolic
Not yet recruiting
- Polycythemia Vera
- Hydroxyurea
- Ruxolitinib
- (no location specified)
Nov 2, 2022
COVID-19, Thrombosis Embolism, Bleeding Trial in Stockholm (Dexamethasone)
Completed
- COVID-19
- +2 more
-
Stockholm, Stockholms Län, SwedenSödersjukhuset
Jun 24, 2022
IBD, Thromboembolism, Coagulation Disorder Trial in Viseu (No intervention was made)
Completed
- Inflammatory Bowel Diseases
- +2 more
- No intervention was made
-
Viseu, PortugalCentro Hospitalar Tondela Viseu
Dec 4, 2021
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)
Recruiting
- Deep-Venous Thrombosis
- IPD Device delivered by Converis
- Fraxiparine
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Apr 6, 2022
Gastrointestinal Tumors, Thromboembolic Event Trial in Tunis (Enoxaparin 4000 IU)
Completed
- Gastrointestinal Neoplasms
- Thromboembolic Event
- Enoxaparin 4000 IU
-
Tunis, Tunis BAB Souika, TunisiaCharles Nicolle Hospital
Jul 27, 2021
Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Tucson (Catheter directed
Recruiting
- Pulmonary Embolism
- +2 more
- Catheter directed therapy
- Systemic anticoagulation
-
Tucson, ArizonaBanner University Medical Center
Sep 21, 2022
Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)
Not yet recruiting
- Juvenile Idiopathic Arthritis
- (no location specified)
Nov 7, 2022
Cardiac Implantable Electronic Devices on the Hemostatic System
Recruiting
- Thromboembolism
- +2 more
- Cardiac implantable electronic device implantation.
- +4 more
-
Ryazan', Ryazan, Russian FederationRyazan State Medical University
Oct 26, 2022
(Called RETAF-PS) UsingPatient Survey to Learn More About
Not yet recruiting
- Prevention of Thromboembolic Events
- Atrial Fibrillation
-
Whippany, New JerseyBayer
Jul 21, 2022
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023
Hepatocellular Carcinoma(HCC) After Systemic Treatments
Enrolling by invitation
- Liver Cancer
- +4 more
- questionnaire survey
-
Wenzhou, Zhejiang, ChinaGang Chen
Jul 1, 2022
Thromboembolic Events in Patients Receiving Kcentra® or Plasma
Completed
- Hemorrhage
- Kcentra®
- Plasma
-
Oakland, CaliforniaStudy Site
May 24, 2021
Investigate if Early Atrial Fibrillation Diagnosis Reduces Risk
Recruiting
- Atrial Fibrillation
- Heart healthy Engagement Program with the Apple Watch Series 5 or later
- Anti-Coagulation Adherence Module with the Apple Watch Series 5 or later
-
San Mateo, CaliforniaEvidation Health
Mar 4, 2022
Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)
Active, not recruiting
- Antithrombin III Deficiency
- Plasma-derived AT-III concentrate
- (no location specified)
May 5, 2022
United Sates That Looks at Safety and Effectiveness of Pradaxa
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Aug 1, 2023
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Aurora, Colorado
- +4 more
Jan 21, 2022
Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)
Not yet recruiting
- Hepatocellular Carcinoma
- Livmoniplimab
- +5 more
- (no location specified)
Oct 26, 2023
Pathways to Mitigate Immune-Related Adverse Events With Cancer
Recruiting
- Cancer
- systemic corticosteroid or biologic
-
Denver, Colorado
- +1 more
Sep 8, 2021
NETs in Solid Cancers Associated WithHigh Risk of Venous
Unknown status
- Pancreatic Cancer
- +2 more
-
Boulogne-Billancourt, Haut De Seine, FranceAmbroise Pare Hospital
Nov 6, 2020
Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack Trial in Korea, Republic of (Antiplatelet Drug, Warfarin)
Not yet recruiting
- Antiphospholipid Syndrome
- +5 more
- Antiplatelet Drug
- Warfarin
-
Anyang, Korea, Republic of
- +34 more
Aug 15, 2023